Raising the Bar: S.T.I. Italia S.R.L. Successfully Passes GDP Audit
Taking Quality The Extra Mile in Pharmaceutical Logistics
STI Italia S.r.l. has successfully demonstrated compliance with Good Distribution Practice (GDP) principles - a key requirement for transporting pharmaceutical products. Passing this audit confirms that our team in Italy meets strict regulatory standards for handling and distributing pharmaceuticals, giving customers confidence that their shipments are managed with precision, care, and full compliance. It is a testament to their commitment to Taking Quality The Extra Mile in pharmaceutical logistics.
A Team Effort Behind the Achievement
Demonstrating compliance with GDP principles required a strong commitment to quality, detailed preparation, and expert knowledge. In December 2023, STI Italy welcomed the Manager QA and Environment from the STI FM holding, to the Bomporto site. His visit supported the team in reviewing processes and ensuring full alignment with GDP requirements, focusing on ISO standards, quality management, and compliance—critical factors for pharmaceutical customers.
The audit process was demanding, requiring thorough documentation, in-depth process reviews, and full adherence to GDP principles. The team successfully demonstrated their ability to meet the highest industry standards, reinforcing the importance of structured quality management in pharmaceutical logistics. Their dedication, expertise, and attention to detail played a key role in achieving this milestone.
What This Achievement Means for STI Italy
"This confirmation of compliance is a recognition of our unwavering dedication to quality and excellence in pharmaceutical logistics. It reinforces our mission to ensure the highest level of compliance and service reliability for our customers. I am incredibly proud of our team for their hard work and commitment in achieving this milestone." – Managing Director, STI Italy
Passing this audit is a significant step for our Italian colleagues, further strengthening their credibility in pharmaceutical logistics. It assures customers that their sensitive shipments are handled with the highest level of care and compliance. Beyond regulatory requirements, it reflects the team’s dedication to maintaining quality at every stage of the logistics process.
Starting 2025 with this achievement highlights STI Italy’s continued focus on quality and compliance. Their commitment to Taking Quality The Extra Mile ensures that pharmaceutical customers can rely on them to meet the highest industry standards. Congratulations to everyone involved—your efforts make a real impact!
A Team Effort Behind the Achievement
Demonstrating compliance with GDP principles required a strong commitment to quality, detailed preparation, and expert knowledge. In December 2023, STI Italy welcomed the Manager QA and Environment from the STI FM holding, to the Bomporto site. His visit supported the team in reviewing processes and ensuring full alignment with GDP requirements, focusing on ISO standards, quality management, and compliance—critical factors for pharmaceutical customers.
The audit process was demanding, requiring thorough documentation, in-depth process reviews, and full adherence to GDP principles. The team successfully demonstrated their ability to meet the highest industry standards, reinforcing the importance of structured quality management in pharmaceutical logistics. Their dedication, expertise, and attention to detail played a key role in achieving this milestone.
What This Achievement Means for STI Italy
"This confirmation of compliance is a recognition of our unwavering dedication to quality and excellence in pharmaceutical logistics. It reinforces our mission to ensure the highest level of compliance and service reliability for our customers. I am incredibly proud of our team for their hard work and commitment in achieving this milestone." – Managing Director, STI Italy
Passing this audit is a significant step for our Italian colleagues, further strengthening their credibility in pharmaceutical logistics. It assures customers that their sensitive shipments are handled with the highest level of care and compliance. Beyond regulatory requirements, it reflects the team’s dedication to maintaining quality at every stage of the logistics process.
Starting 2025 with this achievement highlights STI Italy’s continued focus on quality and compliance. Their commitment to Taking Quality The Extra Mile ensures that pharmaceutical customers can rely on them to meet the highest industry standards. Congratulations to everyone involved—your efforts make a real impact!
